Literature DB >> 12780798

Is macrocytosis a favourable prognostic factor in myelodysplastic syndrome patients without increased blasts?

Akira Matsuda, Motohiro Misumi, Katsuhiko Yoshida, Fumiharu Yagasaki, Yoshihiro Ito, Nobutaka Kawai, Masami Bessho.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12780798     DOI： 10.1046/j.1365-2141.2003.04344.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  [Mean corpuscular volume ≤100 fl was an independent prognostic factor in patients with myelodysplastic syndrome and bone marrow blast<5 percent].

Authors:  Z X Shi; T J Qin; Z F Xu; H J Huang; B Li; S Q Qu; N B Hu; L J Pan; D Liu; Y N Cai; Y D Zhang; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

2.  The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5-azacytidine: Results from the Hellenic 5-azacytidine registry.

Authors:  Panagiotis Diamantopoulos; Dafni Koumbi; Ioannis Kotsianidis; Vasiliki Pappa; Argiris Symeonidis; Athanasios Galanopoulos; Panagiotis Zikos; Helen A Papadaki; Panayiotis Panayiotidis; Maria Dimou; Eleftheria Hatzimichael; George Vassilopoulos; Susan Delimpasis; Despoina Mparmparousi; Sotirios Papageorgiou; Eleni Variami; Marie-Christine Kyrtsonis; Aekaterini Megalakaki; Maria Kotsopoulou; Panagiotis Repousis; Ioannis Adamopoulos; Flora Kontopidou; Dimitrios Christoulas; Alexandra Kourakli; Dimitrios Tsokanas; Menelaos Konstantinos Papoutselis; Georgios Kyriakakis; Nora-Athina Viniou
Journal:  Cancer Med       Date:  2019-03-21       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.